Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 7
Submit an article Journal homepage
502
Views
5
CrossRef citations to date
0
Altmetric
Short Report

In vitro assessment of the allergenicity of novel MF59-adjuvanted pandemic H1N1 influenza vaccine produced in dog kidney cells

Ramon Bencharitiwong Mount Sinai School of Medicine, Pediatrics, 1 Gustave L.Levy Place Box. 1198, New York, NY 10029, United States, +(1)212-241-4908, +(1)212-426-1902 (fax)Correspondence[email protected]
,
Stephanie Leonard Mount Sinai School of Medicine, Pediatrics, 1 Gustave L.Levy Place Box. 1198, New York, NY 10029, United States, +(1)858-966-5961, +(1)858-966-6791 (fax)
,
Theodore Tsai Novartis
&
Anna Nowak-Węgrzyn Mount Sinai School of Medicine, Pediatrics, 1 Gustave L.Levy Place Box. 1198, New York, NY 10029, United States, +(1)212-241-9489, +(1)212-426-1902 (fax)
Pages 863-865 | Received 13 Feb 2012, Accepted 10 Apr 2012, Published online: 01 Jul 2012

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alberto Pérez Rubio & Jose María Eiros. (2018) Cell culture-derived flu vaccine: Present and future. Human Vaccines & Immunotherapeutics 14:8, pages 1874-1882.
Read now
Ilaria Manini, Alexander Domnich, Daniela Amicizia, Stefania Rossi, Teresa Pozzi, Roberto Gasparini, Donatella Panatto & Emanuele Montomoli. (2015) Flucelvax (Optaflu) for seasonal influenza. Expert Review of Vaccines 14:6, pages 789-804.
Read now
Nagendra R Hegde. (2015) Cell culture-based influenza vaccines: A necessary and indispensable investment for the future. Human Vaccines & Immunotherapeutics 11:5, pages 1223-1234.
Read now

Articles from other publishers (2)

Milan Ganguly, Leena Yeolekar, Parikshit Tyagi, Umesh Sagar, Swapnil Narale, Yashodhan Anaspure, Sham Tupe, Kuntinath Wadkar, Nilesh Ingle, Rajeev Dhere, Francesco B. Scorza & Kutub Mahmood. (2020) Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform. Vaccine 38:52, pages 8379-8386.
Crossref
Nagendra R. Hegde, Deepak Kumar, P. Panduranga Rao, P. Krishna Kumari, Yashpal Kaushik, R. Ravikrishnan, Sai D. Prasad & Krishna M. Ella. (2014) Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India. Vaccine 32:29, pages 3636-3643.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.